tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XNCR Stock Latest News

3 Best Stocks to Buy Now, 9/3/2025, According to Top Analysts
Market News3 Best Stocks to Buy Now, 9/3/2025, According to Top Analysts
4d ago
BBIO
VNOM
Xencor downgraded to Neutral at BofA on long development timelines
PremiumThe Fly
Xencor downgraded to Neutral at BofA on long development timelines
5d ago
XNCR
Xencor downgraded to Neutral from Buy at BofA
PremiumThe Fly
Xencor downgraded to Neutral from Buy at BofA
5d ago
XNCR
Xencor price target lowered to $15 from $32 at RBC Capital
PremiumThe Fly
Xencor price target lowered to $15 from $32 at RBC Capital
18d ago
XNCR
Xencor’s XmAb808 Study: A New Frontier in Cancer Treatment
PremiumCompany Announcements
Xencor’s XmAb808 Study: A New Frontier in Cancer Treatment
1M ago
XNCR
Xencor’s XmAb541 Study: A Promising Step in Cancer Treatment
PremiumCompany AnnouncementsXencor’s XmAb541 Study: A Promising Step in Cancer Treatment
1M ago
XNCR
Xencor price target lowered to $26 from $31 at Wedbush
Premium
The Fly
Xencor price target lowered to $26 from $31 at Wedbush
1M ago
XNCR
Xencor’s XmAb942 Shows Promising Efficacy and Strategic Advancements, Earning a Buy Rating
Premium
Ratings
Xencor’s XmAb942 Shows Promising Efficacy and Strategic Advancements, Earning a Buy Rating
1M ago
XNCR
Xencor’s Strategic Advances and Promising Pipeline Drive Buy Rating
PremiumRatings
Xencor’s Strategic Advances and Promising Pipeline Drive Buy Rating
1M ago
XNCR
Xencor, Inc. Reports Revenue Growth Amidst Continued Losses
PremiumCompany Announcements
Xencor, Inc. Reports Revenue Growth Amidst Continued Losses
1M ago
XNCR
Xencor reports Q2 EPS (41c) , consensus (71c)
PremiumThe Fly
Xencor reports Q2 EPS (41c) , consensus (71c)
1M ago
XNCR
Xencor’s XmAb541 Study Completion: A Potential Game-Changer in Oncology
PremiumCompany Announcements
Xencor’s XmAb541 Study Completion: A Potential Game-Changer in Oncology
1M ago
XNCR
Xencor Appoints Raymond Deshaies to Board of Directors
PremiumCompany AnnouncementsXencor Appoints Raymond Deshaies to Board of Directors
1M ago
8K
XNCR
Xencor’s XmAb819 Study: A Promising Step in Renal Cell Carcinoma Treatment
Premium
Company Announcements
Xencor’s XmAb819 Study: A Promising Step in Renal Cell Carcinoma Treatment
1M ago
XNCR
Xencor’s Phase 2 Study on Vudalimab in Prostate Cancer: Key Update and Market Impact
Premium
Company Announcements
Xencor’s Phase 2 Study on Vudalimab in Prostate Cancer: Key Update and Market Impact
2M ago
XNCR
Xencor’s Promising Developments in Autoimmune and Oncology Drive Buy Rating
PremiumRatings
Xencor’s Promising Developments in Autoimmune and Oncology Drive Buy Rating
3M ago
XNCR
Xencor Holds Annual Stockholders Meeting on June 12
PremiumCompany Announcements
Xencor Holds Annual Stockholders Meeting on June 12
3M ago
8K
XNCR
Xencor Inc. Reports Revenue Growth Amidst Ongoing R&D Investments
PremiumCompany Announcements
Xencor Inc. Reports Revenue Growth Amidst Ongoing R&D Investments
4M ago
XNCR
Xencor’s Growth Potential and Strategic Positioning Justify Buy Rating and $38 Price Target
PremiumRatings
Xencor’s Growth Potential and Strategic Positioning Justify Buy Rating and $38 Price Target
4M ago
XNCR
Xencor’s Promising Pipeline and Strong Financials Present Favorable Risk/Reward Opportunity Ahead of Key 2025 Data Readouts
PremiumRatingsXencor’s Promising Pipeline and Strong Financials Present Favorable Risk/Reward Opportunity Ahead of Key 2025 Data Readouts
4M ago
XNCR
Xencor price target lowered to $6 from $22 at Barclays
Premium
The Fly
Xencor price target lowered to $6 from $22 at Barclays
4M ago
XNCR
Xencor’s Promising Pipeline and Strategic Collaborations Justify Buy Rating
Premium
Ratings
Xencor’s Promising Pipeline and Strategic Collaborations Justify Buy Rating
4M ago
XNCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >